Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03437200
Title Combination of Chemoradiation With Immunotherapy in Inoperable œsophageal Cancer (CRUCIAL)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors European Organisation for Research and Treatment of Cancer - EORTC
Indications

esophagus adenocarcinoma

esophagus squamous cell carcinoma

Therapies

Nivolumab

Ipilimumab + Nivolumab

Age Groups: senior | adult
Covered Countries


No variant requirements are available.